Vasopressors & The Older Patient - The 65 Trial

April 27, 2020 00:22:04
Vasopressors & The Older Patient - The 65 Trial
Critical Care Perspectives in Emergency Medicine
Vasopressors & The Older Patient - The 65 Trial

Apr 27 2020 | 00:22:04

/

Show Notes

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic HTN. Recent literature, however, suggests increased mortality in older patients who are exposed to larger quantities of vasopressor medications.  In this podcast, we do a deep dive into the recently published 65 Trial, which sought to evaluate the effect of permissive hypotension in older patients with vasodilatory hypotension.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

March 25, 2017 00:17:05
Episode Cover

High Dose NTG in ACPE

ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema.  Is it safe? ...

Listen

Episode 0

March 29, 2021 00:26:01
Episode Cover

ECMO for Cardiac Arrest and Massive PE

Despite continued advances in resuscitation, favorable outcomes for patients with OHCA who receive standard resuscitation remain dismal.  In recent years there has been significant...

Listen

Episode 0

August 28, 2020 00:25:38
Episode Cover

Ketamine in the Critically Ill

Ketamine is a well-known anesthetic used commonly in the ED for RSI and procedural sedation.  In this podcast, we review the use of ketamine...

Listen